X4 Pharmaceuticals (XFOR) Return on Sales [ROS] (2018 - 2026)
X4 Pharmaceuticals (XFOR) recorded Return on Sales [ROS] of -186.13% in Q2 2026, up 1143.41 percentage points from -1329.55% a year earlier and up 563.72 percentage points from the prior quarter.
X4 Pharmaceuticals (XFOR) Return on Sales [ROS] (2018 - 2026) Analysis & Trends
On a TTM basis, X4 Pharmaceuticals' Return on Sales [ROS] came in at -554.71% as of Jun 30, 2026, down 231.62 percentage points year-over-year; for FY2025, it came in at -247.44%, up 1176.14 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of +1748.36 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -1423.58% in FY2024.
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q1 2025.
- On a year-over-year basis, Return on Sales [ROS] rose in three of the last five quarters, with an average year-over-year change of -1472.53 percentage points.
- Per Business Quant, the preceding three quarters came in at -749.85% (Q1 2026), -922.86% (Q4 2025) and -1558.58% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | X4 Pharmaceuticals | 357.55 Mn | -341.13 Mn | 7.19 Mn | -186.13% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -186.13% |
| Mar 31, 2026 | -749.85% |
| Dec 31, 2025 | -922.86% |
| Sep 30, 2025 | -1,558.58% |
| Jun 30, 2025 | -1,329.55% |
| Mar 31, 2025 | -32.78% |
| Dec 31, 2024 | -2,490.59% |
| Sep 30, 2024 | -6,160.71% |
| Jun 30, 2024 | 12,629.31% |
| Dec 31, 2020 | -1,995.80% |
| Sep 30, 2020 | -1,769.80% |
| Jun 30, 2020 | -1,769.67% |
| Mar 31, 2020 | -352.70% |
| Sep 30, 2019 | -1,396.63% |
| Dec 31, 2018 | -230.11% |
X4 Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();